Accéder au contenu
Merck

11112589001

Roche

Blocking Reagent

For ELISA

Synonyme(s) :

blocking reagent

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

A propos de cet article

UNSPSC Code:
12352200
NACRES:
NA.54

Principaux documents

Voir toute la documentation
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Nom du produit

Blocking Reagent, For ELISA

form

powder

packaging

pkg of 27 g

manufacturer/tradename

Roche

storage temp.

2-8°C

Quality Level

100

Catégories apparentées

Application

For research use only. Not for use in diagnostic procedures.
Blocking reagent has been used as a blocking reagent in:
  • ELISA
  • Immunofluorescence
  • In situ hybridization

General description

Blocking reagent is used for blocking of nonspecific binding sites in ELISA procedures.

Other Notes

For life science research only. Not for use in diagnostic procedures.

Preparation Note

Storage conditions (working solution): Autoclaved stock solution can be stored for several days to one week either unopened at 15 to 25 °C or at 2 to 8 °C after opening. Alternatively, the stock solution can be stored in aliquots at -15 to -15 °C for up to 6 months.

Classe de stockage

11 - Combustible Solids

wgk

WGK 1

flash_point_f

does not flash

flash_point_c

does not flash

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
66371300
55755600
53368400
40743400
30819300

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Sara Mravinacova et al.
New biotechnology, 66, 46-52 (2021-10-11)
Highly accurate serological tests are key to assessing the prevalence of SARS-CoV-2 antibodies and the level of immunity in the population. This is important to predict the current and future status of the pandemic. With the recent emergence of new
David Drews et al.
BMC developmental biology, 9, 45-45 (2009-07-30)
The transcription factor Yin Yang 2 (YY2) shares a structural and functional highly homologue DNA-binding domain with the ubiquitously expressed YY1 protein, which has been implicated in regulating fundamental biological processes. However, the biological relevance of YY2 has not been
Anja K Wege et al.
mAbs, 6(4), 968-977 (2014-05-30)
Humanized tumor mice (HTM) were generated by the co-transplantation of human hematopoietic stem cells and human breast cancer cells overexpressing HER2 into neonatal NOD-scid IL2Rγ(null) (NSG) mice. These mice are characterized by the development of a human immune system in
Anneke H Hellinga et al.
International journal of molecular sciences, 21(23) (2020-12-03)
Bovine immunoglobulin G (bIgG) was previously shown to enhance innate immune responses to toll-like receptor (TLR) stimulation, via induction of trained immunity. In this study, we investigated whether minimally processed dairy streams with high levels of whey proteins as potential
Laurens J Lambert et al.
PloS one, 8(12), e82110-e82110 (2013-12-11)
During B cell activation, the DNA lesions that initiate somatic hypermutation and class switch recombination are introduced by activation-induced cytidine deaminase (AID). AID is a highly mutagenic protein that is maintained in the cytoplasm at steady state, however AID is

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique